Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis

Detalles Bibliográficos
Autores principales: Yi, Jun Ho, Kim, Seok Jin, Yoon, Dok Hyun, Suh, Cheolwon, Chang, Myung Hee, Yang, Deok Hwan, Jo, Jae‐Cheol, Hyun, Shin Young, Eom, Hyeon‐Seok, Lee, Jeong‐Ok, Kwon, Ji Hyun, Han, Sang Hoon, Lee, Seung‐Shin, Kwak, Jae‐Yong, Kim, Se Hyung, Kim, Dae Sik, Lee, Ji Hyun, Oh, Sung Yong, Ryoo, Hun Mo, Kim, Hyo Jung, Kim, Won Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968880/
https://www.ncbi.nlm.nih.gov/pubmed/33626235
http://dx.doi.org/10.1002/cac2.12150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968880/
https://www.ncbi.nlm.nih.gov/pubmed/33626235
http://dx.doi.org/10.1002/cac2.12150

Ejemplares similares